The efficacy and selectivity of tumor cell killing by Akt inhibitors are substantially increased by chloroquine

被引:61
作者
Hu, Changkun [1 ]
Solomon, V. Raja [1 ]
Ulibarri, Gerardo [2 ]
Lee, Hoyun [1 ]
机构
[1] Sudbury Reg Hosp, Northeastern Ontario Reg Canc Ctr, Tumor Biol Grp, Sudbury, ON P3E 5J1, Canada
[2] Laurentian Univ, Dept Chem & Biochem, Sudbury, ON P3E 2C6, Canada
关键词
chloroquine; PI3K-Akt inhibitors; breast cancer; cell killing; sensitization; chemotherapeutics;
D O I
10.1016/j.bmc.2008.07.076
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study was to evaluate the enhancement value of chloroquine (CQ) in cancer cell killing when used in combination with Akt inhibitors. The results showed that the combination of CQ and Akt inhibitors is much more effective than either one alone. Importantly, the CQ-mediated chemosensitization of cell killing effects by Akt inhibitors is cancer specific. In particular, when combined with 10 mu M CQ, 1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one (an Akt1 and 2 inhibitor; compound 8) killed cancer cells 10-120 times more effectively than normal cells. Thus, CQ is a very effective and cancer-specific chemosensitizer when used in combination with Akt inhibitors. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:7888 / 7893
页数:6
相关论文
共 52 条
[31]   Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines [J].
Nakatani, K ;
Thompson, DA ;
Barthel, A ;
Sakaue, H ;
Liu, W ;
Weigel, RJ ;
Roth, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (31) :21528-21532
[32]   Susceptibility of lysosomes to rupture is a determinant for plasma membrane disruption in tumor necrosis factor alpha-induced cell death [J].
Ono, K ;
Kim, SO ;
Han, JH .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (02) :665-676
[33]   Resistance to tumor necrosis factor-induced cell death mediated by PMCA4 deficiency [J].
Ono, K ;
Wang, XF ;
Han, JH .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (24) :8276-8288
[34]   Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients [J].
Pérez-Tenorio, G ;
Stål, O .
BRITISH JOURNAL OF CANCER, 2002, 86 (04) :540-545
[35]   New insights into the antiviral effects of chloroquine [J].
Savarino, A ;
Di Trani, L ;
Donatelli, I ;
Cauda, R ;
Cassone, A .
LANCET INFECTIOUS DISEASES, 2006, 6 (02) :67-69
[36]   Effects of chloroquine on viral infections: an old drug against today's diseases? [J].
Savarino, A ;
Boelaert, JR ;
Cassone, A ;
Majori, G ;
Cauda, R .
LANCET INFECTIOUS DISEASES, 2003, 3 (11) :722-727
[37]   The anti-HIV-1 activity of chloroquine [J].
Savarino, A ;
Gennero, L ;
Sperber, K ;
Boelaert, JR .
JOURNAL OF CLINICAL VIROLOGY, 2001, 20 (03) :131-135
[38]   NEW COLORIMETRIC CYTOTOXICITY ASSAY FOR ANTICANCER-DRUG SCREENING [J].
SKEHAN, P ;
STORENG, R ;
SCUDIERO, D ;
MONKS, A ;
MCMAHON, J ;
VISTICA, D ;
WARREN, JT ;
BOKESCH, H ;
KENNEY, S ;
BOYD, MR .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (13) :1107-1112
[39]   Adding chloroquine to conventional treatment for glioblastoma multiforme -: A randomized, double-blind, placebo-controlled trial [J].
Sotelo, J ;
Briceño, E ;
López-González, MA .
ANNALS OF INTERNAL MEDICINE, 2006, 144 (05) :337-343
[40]   INDUCTION OF TRANSFORMATION AND CONTINUOUS CELL-LINES FROM NORMAL HUMAN MAMMARY EPITHELIAL-CELLS AFTER EXPOSURE TO BENZO[A]PYRENE [J].
STAMPFER, MR ;
BARTLEY, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (08) :2394-2398